Top 5 Tissue Microarray (TMA) Companies Delivering High-Quality Human Tissue Microarrays to Researchers in China China has become one of the world’s leading hubs for biomedical innovation, with significant investments in oncology, precision medicine, molecular pathology, biomarker discovery, and translational…
Lung Cancer Tissue Microarrays: Enabling Better Tumor Understanding and Cancer Research Lung cancer remains one of the leading causes of cancer-related mortality worldwide, making continuous research essential for improving diagnosis, treatment strategies, and patient outcomes. As scientists work to better…
Breast Cancer Research Using Tissue Microarrays: Advancing Biomarker Discovery and Precision Medicine Breast cancer remains one of the most extensively studied cancers worldwide, with researchers continuously working to improve early detection, treatment selection, and patient outcomes. One of the key…
5 Best Tissue Microarray Providers for Cancer Research Top Tissue Microarray Provider Options for Oncology, Biomarker Discovery, and Translational Studies Cancer research demands precision, consistency, and clinically relevant data. Choosing the right tissue microarray provider is not just a procurement…
7 Best Tissue Microarray Providers for Research and Clinical Applications Top Tissue Microarray Provider Companies Selecting the right tissue microarray provider can directly impact the quality, reproducibility, and translational value of your research. Whether you’re working on biomarker discovery, oncology…
Celebrating a New Academic Chapter: Dr. Chua Jia Xin Appointed Associate Professor at Xiamen University MYmAb Biologics is proud to share an exciting milestone in our journey. Our founder, Dr Chua Jia Xin, has officially joined Xiamen University as an…
MYmAb Biologics Recognised as VIP at Healthcare+ Expo Taiwan, Strengthening Its Global Healthcare Presence MYmAb Biologics is honoured to be invited as a VIP guest at the Healthcare+ Expo Taiwan, held at the Taipei Nangang Exhibition Center. The invitation reflects…
MYmAb Biologics Expands Global Reach Through Strategic Distributor Partnerships, Advancing Equity in Cancer Research Strengthening its international footprint, MYmAb Biologics has entered strategic collaborations with two well-established global distributors: ABreal Biotech and 2BScientific. These partnerships mark a significant milestone in…
Dr Chua Jia Xin: Advancing Therapeutic Antibodies for Malaysia and Beyond Dr Chua Jia Xin’s recognition as the National Young Scientist Award 2025 recipient in the Medical category highlights the rising strength of Malaysia’s biotechnology talent. As the founder of…
Tissue Microarray for Prostate Cancer: Accelerating Biomarker Discovery and Precision Oncology In the evolving field of oncology research, precision, scalability, and reproducibility are key drivers of progress. Prostate cancer, one of the most prevalent malignancies among men worldwide, presents significant…